Eieling Technology Limited was established in 2018. The flagship product, Liverscan, is a cutting-edge medical device based on an invention from The Hong Kong Polytechnic University, and now transformed into a real-world impact medical product. Eieling has secured funding from prestigious sources, including the PolyVentures Angel Fund Scheme and private investors.